Changes of Airway Reactivity after Mycoplasma Pneumoniae Infection in Children: A Study for Early Precautions against Pediatric Asthma
-
Han Zhang
,
Gaomei Lv
,
Yunxiao Shang
,
Liyun Liu
,
Yun Xiang
,
Jing Feng
,
Zhijia Wang
Abstract
The relationship between Mycoplasma pneumoniae (MP) infection and asthma has rarely been explored through examination of airway reactivity. The aim of this study was to determine airway reactivity changes after MP infection in children. First, 106 children were divided into four groups according to the existence of MP infection and/or asthma. Then children with only MP belonged to the MP group; children who had both MP infection and asthma belonged to the MP+A group; children with asthma but not MP infection belonged to the non-MP +A group; normal children were classified as normal control (NC) group. Each subject underwent a bronchial provocation test (BPT) after effectively controlling the symptoms. Airway hyperresponsiveness (AHR) parameters were compared among the groups. BPT positive rates were also calculated and compared. All AHR parameters decreased following MP infection, with a more significant decrease of small airway reactivity related indexes. The BPT-positive rate in the MP +A group was significantly higher than that in the MP group. Large airway reactivity showed no significant differences between the MP+A and non-MP+A groups, while the small airway reactivity augmented more significantly in the MP +A group. MP infection caused increased reactivity of both large and small airways in lungs, and BPT-positive identification in some patients.
1. Wang K, Gill P, Perera R, Thomson A, Mant D, Harnden A. Clinical symptoms and signs for the diagnosis of Mycoplasma pneumoniae in children and adolescents withcommunity-acquired pneumonia. Cochrane Database Syst Rev 2012; 10:CD009175.
2. Gaillat J, Flahault A, deBarbeyrac B, Orfila J, Portier H, Ducroix JP, et al. Community epidemiology of Chlamydia and Mycoplasma pneumonia in LRTI in France over 29 months. Eur J Epidemiol 2005; 20(7):643-51.
3. Macfarlane J, Holmes W, Gard P, Macfarlane R, Rose D, Weston V, et al. Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 2001; 56(2):109-14.
4. Nagalingam NA, Adesiyun AA, Swanston WH, Bartholomew M. Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in pneumonia patients in four major hospitals in Trinidad. New Microbiol 2004;27(4):345-51.
5. Yu J, Yoo Y, Kim DK, Kang H, Koh YY. Distributions of antibody titers to Mycoplasma pneumoniae in Korean children in 2000-2003. J Korean Med Sci 2005;20(4):542-7.
6. Ngeow YF, Suwanjutha S, Chantarojanasriri T, Wang F, Saniel M, Alejandria M, et al. An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia. Int J Infect Dis 2005;9(3):144-53.
7. Broughton RA. Infections due to Mycoplasma pneumoniae in childhood. Pediatr Infect Dis 1986;5(1):71-85.
8. Cosentini R, Tarsia P, Canetta C, Graziadei G, Brambilla AM, Aliberti S, et al. Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection. Respir Res 2008,9:48.
9. Martin RJ. Infections and asthma. Clin Chest Med 2006;27(1):87-98.
10. MacDowell AL, Bacharier LB. Infectious triggers of asthma. Immunol Allergy Clin North Am 2005; 25(1):45-66.
11. Watanabe H, Uruma T, Nakamura H, Aoshiba K. The role of Mycoplasma pneumoniae infection in the initial onset and exacerbations of asthma. Allergy Asthma Proc 2014; 35(3):204-10.
12. Anderson SD, Brannan JD, Chan HK. Use of aerosols for bronchial provocation testing in t he laboratory: where we have been and where we are going. J Aerosol Med 2002,15 (3):313-24.
13. Hanhan U, Orlowski J, Fiallos M. Association of Mycoplasma pneumoniae infections with status asthmaticus. Open Respir Med J 2008; 2:35-8.
14. Ou CY, Tseng YF, Chiou YH, Nong BR, Huang YF, Hsieh KS. The role of mycoplasma pneumoniae in acute exacerbation of asthma in children[J]. Acta Paediatr Taiwan 2008; 49(1):14 - 8.
15. Biscardi S, Lorrot M, Marc E, Moulin F, Boutonnat- Faucher B, Heilbronner C, et al. Mycoplasma pneumoniae and asthma in children. Clin Infect Dis 2004;38(10):1341-6.
16. Esposito S, Blasi F, Arosio C, Fioravanti L, Fagetti L, Droghetti R, et al. Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J 2000; 16(6):1142-6.
17. Tang SP, Liu YL, Dong L, Hua YH, Guo YH, Lu Q.Etiological analysis of the children with non-specific chronic cough in Fuzhou area of Fujian province. Zhonghua Er Ke Za Zhi 2011; 49(2):103-5.
18. Nisar N, Guleria R, Kumar S, Chand Chawla T, Ranjan Biswas N. Mycoplasma pneumoniae and its role in asthma. Postgrad Med J 2007; 83(976):100-4.
19. Leuppi JD. Bronchoprovocation tests in asthma: direct versus indirect challenges. Curr Opin Pulm Med 2014;20(1):31-6.
20. Anderson SD. Indirect challenge tests: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 2010; 138(2 Suppl):25S-30S.
21. Martin RJ, Chu HW, Honour JM, Harbeck RJ. Airway inflammation and bronchial yperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am J Respir Cell Mol Biol 2001; 24(5):577-82.
22. Yang J, Hooper WC, Phillips DJ, Talkington DF.Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev 2004; 15(2-3):157-68.
23. Chu HW, Kraft M, Krause JE, Rex MD, Martin RJ.Substance P and its receptor neurokinin 1 expression in asthmatic airways. J Allergy Clin Immunol 2000;106(4):713-22.
| Files | ||
| Issue | Vol 14, No 5 (2015) | |
| Section | Original Article(s) | |
| Keywords | ||
| Allergen bronchial provocation test Asthma Bronchial hyperreactivity Children Mycoplasma pneumoniae | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
